{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:15:25Z","timestamp":1792181725792,"version":"4.4.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T00:00:00Z","timestamp":1550880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"EBOVAC 1"},{"name":"EBOVAC 2"},{"name":"EBOMAN","award":["115847"],"award-info":[{"award-number":["115847"]}]},{"name":"BODAC"},{"name":"Janssen Vaccines and Prevention,","award":["HHSN272200800056C"],"award-info":[{"award-number":["HHSN272200800056C"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,5]]},"DOI":"10.1093\/infdis\/jiz070","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T12:10:35Z","timestamp":1550578235000},"page":"46-56","source":"Crossref","is-referenced-by-count":145,"title":["Safety and Immunogenicity of a 2-Dose Heterologous Vaccination Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Uganda and Tanzania"],"prefix":"10.1093","volume":"220","author":[{"given":"Zacchaeus","family":"Anywaine","sequence":"first","affiliation":[{"name":"Medical Research Council\/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Whitworth","sequence":"additional","affiliation":[{"name":"London School of Hygiene and Tropical Medicine, London, United Kingdom"},{"name":"Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pontiano","family":"Kaleebu","sequence":"additional","affiliation":[{"name":"Medical Research Council\/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Praygod","sequence":"additional","affiliation":[{"name":"Mwanza Research Center, National Institute for Medical Research, Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgi","family":"Shukarev","sequence":"additional","affiliation":[{"name":"Janssen Vaccines and Prevention, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Manno","sequence":"additional","affiliation":[{"name":"London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saidi","family":"Kapiga","sequence":"additional","affiliation":[{"name":"London School of Hygiene and Tropical Medicine, London, United Kingdom"},{"name":"Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Grosskurth","sequence":"additional","affiliation":[{"name":"London School of Hygiene and Tropical Medicine, London, United Kingdom"},{"name":"Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Kalluvya","sequence":"additional","affiliation":[{"name":"Bugando Medical Center, Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viki","family":"Bockstal","sequence":"additional","affiliation":[{"name":"Janssen Vaccines and Prevention, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dickson","family":"Anumendem","sequence":"additional","affiliation":[{"name":"Janssen Vaccines and Prevention, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Luhn","sequence":"additional","affiliation":[{"name":"Janssen Vaccines and Prevention, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Robinson","sequence":"additional","affiliation":[{"name":"Janssen Vaccines and Prevention, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macaya","family":"Douoguih","sequence":"additional","affiliation":[{"name":"Janssen Vaccines and Prevention, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Watson-Jones","sequence":"additional","affiliation":[{"name":"London School of Hygiene and Tropical Medicine, London, United Kingdom"},{"name":"Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,2,23]]},"reference":[{"key":"2019060500252285300_CIT0001","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.je.2016.09.010","article-title":"Epidemiology of ebolavirus disease (EVD) and occupational EVD in health care workers in Sub-Saharan Africa: Need for strengthened public health preparedness","volume":"27","author":"Ngatu","year":"2017","journal-title":"J Epidemiol"},{"key":"2019060500252285300_CIT0002","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1186\/s12879-016-2045-6","article-title":"How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence","volume":"16","author":"Nyakarahuka","year":"2016","journal-title":"BMC Infect Dis"},{"key":"2019060500252285300_CIT0003","author":"Centers for Disease Control and Prevention (CDC)","year":"2016"},{"key":"2019060500252285300_CIT0004","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nature19790","article-title":"The evolution of Ebola virus: Insights from the 2013-2016 epidemic","volume":"538","author":"Holmes","year":"2016","journal-title":"Nature"},{"key":"2019060500252285300_CIT0005","author":"Centers for Disease Control and Prevention (CDC)","year":"2015"},{"key":"2019060500252285300_CIT0006","author":"Centers for Disease Control and Prevention (CDC)","year":"2017"},{"key":"2019060500252285300_CIT0007","first-page":"73","article-title":"Outbreak of Ebola hemorrhagic fever: Uganda, August 2000 \u2013 January 2001","volume":"50","author":"Oyok","year":"2001","journal-title":"MMWR Weekly"},{"key":"2019060500252285300_CIT0008","unstructured":"World Health Organization (WHO). Ebola virus disease \u2013 Democratic Republic of the Congo 2017. http:\/\/www.who.int\/csr\/don\/13-may-2017-ebola-drc\/en\/. Accessed April 2018."},{"key":"2019060500252285300_CIT0009","unstructured":"World Health Organization (WHO). Ebola virus disease Democratic Republic of Congo: external situation report 1. 2018. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/272509\/SITREP-EVD-DRC-20180511.pdf?ua=1. Accessed July 2018."},{"key":"2019060500252285300_CIT0010","unstructured":"World Health Organization (WHO). Ebola virus disease - Ebola situation reports: Democratic Republic of the Congo. 2018. http:\/\/www.who.int\/ebola\/situation-reports\/drc-2018\/en\/. Accessed August 2018."},{"key":"2019060500252285300_CIT0011","article-title":"A review of Phase 1 trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?","volume":"372:20160295","author":"Lambe","year":"2017","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2019060500252285300_CIT0012","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.2016.4218","article-title":"Safety and immunogenicity of novel adenovirus type 26- and modified vaccinia ankara-vectored Ebola vaccines: a randomized clinical trial","volume":"315","author":"Milligan","year":"2016","journal-title":"JAMA"},{"key":"2019060500252285300_CIT0013","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/21645515.2017.1264755","article-title":"A two-dose heterologous prime-boost vaccine regimen eliciting sustained immune responses to Ebola Zaire could support a preventive strategy for future outbreaks","volume":"13","author":"Shukarev","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"2019060500252285300_CIT0014","unstructured":"WHO Intelligence Blueprint. MVA platform partnership. http:\/\/www.who.int\/blueprint\/what\/research-development\/MVA-presentation.pdf. Accessed March 2019."},{"key":"2019060500252285300_CIT0015","article-title":"Randomized clinical trial examining safety and immunogenicity of heterologous prime-boost Ebola vaccines, Ad26.ZEBOV and MVA-BN-Filo: 12-month results in Kenyan healthy volunteers","author":"Mutua","year":"2018","journal-title":"J Infect Dis"},{"key":"2019060500252285300_CIT0016","author":"Division of Microbiology and Infectious Diseases (DMID)","year":"2007"},{"key":"2019060500252285300_CIT0017","author":"Guidance for Industry"},{"key":"2019060500252285300_CIT0018","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1086\/524749","article-title":"Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the advisory committee on immunization practices and the Armed Forces Epidemiological Board","volume":"46 Suppl 3","author":"Neff","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2019060500252285300_CIT0019","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1172\/JCI60202","article-title":"Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine","volume":"122","author":"Frahm","year":"2012","journal-title":"J Clin Invest"},{"key":"2019060500252285300_CIT0020","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/jama.2016.20644","article-title":"Immune responses to novel adenovirus type 26 and modified vaccinia virus ankara-vectored Ebola vaccines at 1 year","volume":"317","author":"Winslow","year":"2017","journal-title":"JAMA"},{"key":"2019060500252285300_CIT0021","doi-asserted-by":"crossref","first-page":"158ra146","DOI":"10.1126\/scitranslmed.3004582","article-title":"Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates","volume":"4","author":"Wong","year":"2012","journal-title":"Sci Transl Med"},{"key":"2019060500252285300_CIT0022","first-page":"997","article-title":"Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread","volume":"61","author":"Baron","year":"1983","journal-title":"Bull World Health Organ"},{"key":"2019060500252285300_CIT0023","unstructured":"World Health Organization (WHO). World Malaria report. United Republic of Tanzania. 2010. http:\/\/www.who.int\/malaria\/publications\/country-profiles\/profile_tza_en.pdf?ua=1. Accessed April 2018."},{"key":"2019060500252285300_CIT0024","unstructured":"World Health Organization (WHO). Malaria publications. Country profiles. http:\/\/www.who.int\/malaria\/publications\/country-profiles. Accessed April 2018."},{"key":"2019060500252285300_CIT0025","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1475-2875-10-138","article-title":"The clinical burden of malaria in Nairobi: a historical review and contemporary audit","volume":"10","author":"Mudhune","year":"2011","journal-title":"Malar J"},{"key":"2019060500252285300_CIT0026","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJMoa1614067","article-title":"Phase 2 placebo-controlled trial of two vaccines to prevent Ebola in Liberia","volume":"377","author":"Kennedy","year":"2017","journal-title":"N Engl J Med"},{"key":"2019060500252285300_CIT0027","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"2019060500252285300_CIT0028","unstructured":"World Health Organization (WHO). Ebola virus disease \u2013 Democratic Republic of the Congo: update on ring vaccination. 2018. http:\/\/www.who.int\/csr\/don\/21-may-2018-ebola-drc\/en\/. Accessed July 2018."},{"key":"2019060500252285300_CIT0029","author":"World Health Organization (WHO)"},{"key":"2019060500252285300_CIT0030","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1414216","article-title":"A recombinant vesicular stomatitis virus Ebola vaccine","volume":"376","author":"Regules","year":"2017","journal-title":"N Engl J Med"},{"key":"2019060500252285300_CIT0031","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1473-3099(15)00362-X","article-title":"Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial","volume":"16","author":"Tapia","year":"2016","journal-title":"Lancet Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/220\/1\/46\/28767091\/jiz070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T04:25:42Z","timestamp":1559708742000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/220\/1\/46\/5364034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,23]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,2,23]]},"published-print":{"date-parts":[[2019,6,5]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiz070","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7,1]]},"published":{"date-parts":[[2019,2,23]]}}}